510(k) K232202

Aperio GT 450 DX by Leica Biosystems Imaging, Inc. — Product Code PSY

K232202 is an FDA 510(k) premarket notification submitted by Leica Biosystems Imaging, Inc. for the device "Aperio GT 450 DX". The FDA issued a decision of Substantially Equivalent on Apr 16, 2024. The device falls under product code PSY (Whole Slide Imaging System), a Class II device regulated under 21 CFR 864.3700. Leica Biosystems Imaging, Inc. has 4 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 16, 2024
Date Received
Jul 25, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Whole Slide Imaging System
Device Class
Class II
Regulation Number
864.3700
Review Panel
PA
Submission Type
510(k)

The whole slide imaging system is an automated digital slide creation, viewing, and management system intended as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed, paraffin-embedded (FFPE) tissue. The system generates digital images that would otherwise be appropriate for manual visualization by conventional brightfield microscopy. The whole slide imaging system is not intended for use with slides prepared from frozen tissue, cytology, and non-FFPE hematopathology specimens (e.g., peripheral blood smear).

Need the full FDA record for Leica Biosystems Imaging, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K232202. Report a data issue: hello@regdatalab.com.